Next Article in Journal
N-(2,2-Diphenylethyl)-4-nitrobenzamide
Previous Article in Journal
Four-Step Synthesis of 3-Allyl-2-(allyloxy)-5-bromoaniline from 2-Allylphenol
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-Dioxide

1
Institute of Chemical Sciences, School of Engineering & Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK
2
Department of Chemistry, University of Cyprus, P.O. Box 20537, Nicosia 1678, Cyprus
3
Department of Life Sciences, School of Sciences, European University Cyprus, 6 Diogenis Str., Engomi, P.O. Box 22006, Nicosia 1516, Cyprus
*
Authors to whom correspondence should be addressed.
Molbank 2024, 2024(1), M1774; https://doi.org/10.3390/M1774
Submission received: 17 January 2024 / Revised: 5 February 2024 / Accepted: 7 February 2024 / Published: 12 February 2024
(This article belongs to the Section Organic Synthesis)

Abstract

:
3,5-Diphenyl-4H-1,2,6-thiadiazin-4-one treated with meta-chloroperoxybenzoic acid undergoes an oxidative ring contraction to give 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide in a 29% yield, the structure of which is supported by single-crystal X-ray diffraction analysis and the available spectroscopic data.

1. Introduction

1,2,5-Thiadiazoles are well-studied heterocycles with numerous applications in medicinal chemistry and materials science. Their chemistry and applications have been reviewed [1,2]. Examples of 1,2,5-thiadiazole-containing drugs are the antihypertensive drug Timolol and Tizanidine used in the treatment of multiple sclerosis (Figure 1). S-Oxidized 1,2,5-thiadiazole 1,1-dioxides also have many applications and selected examples act as pan-Kras inhibitors [3], indoleamine 2,3-dioxygenase inhibitors [4] and histamine H2-receptor antagonists (cf. compound 1, Figure 1) [5].
During our studies on 4H-1,2,6-thiadiazines [6], we discovered several unexpected ring contractions to give 1,2,5-thiadiazoles (Scheme 1): The first discovery involved the acid and/or thermal mediated double Wagner−Meerwein-mediated ring contraction of 3′5′-diarylspiro(benzo[d][1,3]dioxole-2,4′-[1,2,6]thiadiazines) 2 to give 3-aryl-4-(2-arylbenzo[d][1,3]dioxol-2-yl)-1,2,5-thiadiazoles 3 in near-quantitative yields [7]. Subsequently, we discovered that heating a solution of benzo[e][1,2,6]thiadiazino[3,4-b][1,4]diazepin-10(11H)-one (4) led to the formation of 2-(4-chloro-1,2,5-thiadiazol-3-yl)-quinazolin-4(3H)-one (5) [8]. More recently, we reported the photochemically mediated oxidative ring contraction of 1,2,6-thiadiazines 6 to 1,2,5-thiadiazol-3(2H)-one 1-oxides 7 under ambient conditions [9]. The reaction mechanism was revealed as a chemoselective [3 + 2] cycloaddition forming an endoperoxide, followed by ring contraction with selective carbon atom excision and complete atom economy.
Aside from our work, only one synthesis of 1,2,5-thiadiazoles by ring transformations of six-membered rings is known: the ring contraction of 1,2,6-thiadiazine 1,1-dioxides 8 with strong acid to give thiadiazolinones 9 in a low yield [10] (Scheme 2). In contrast, there are several methods that start from five-membered rings. N-Alkylpyrrole 10 can under a cycloaddition reaction with trithiazyl trichloride to afford 1,2,5-bithiadiazole 11 [11] (Scheme 2). Substituted isoxazoles 12 can react with a tetrasulfur tetranitride–antimony pentachloride complex to afford 3-substituted 1,2,5-thiadiazoles 13 and 14 in medium yields [12] (Scheme 2). Thiadiazoliums 15 can be converted to thiadiazoles 16 by treatment with ammonia [13] (Scheme 2). Some electron-poor 1,2,3-triazoles 17 were converted to 1,2,5-thiadiazoles 18 by reaction with trithiazyl trichloride [14] (Scheme 2).
Herein, we report the ring contraction of 3,5-diphenyl-4H-1,2,6-thiadiazin-4-one (6a) to 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide (19), mediated by the treatment of the former with meta-chloroperoxybenzoic acid (m-CPBA) in dichloromethane (DCM). This transformation furthers our understanding of the reactivity of thiadiazines and aligns with the broader theme of exploring novel and unexpected pathways in sulfur–nitrogen heterocycle chemistry.

2. Results and Discussion

Recently, we studied S-oxidations of 1,2,6-thiadiazines to access sulfoxide and sulfone analogs [15,16]. In an attempt to explore the reactivity of thiadiazine 6a towards alternative oxidants, we expected to obtain thiadiazine sulfoxide 20 (Scheme 3). However, an unexpected discovery was made: when m-CPBA (four equiv. in total) was added to a DCM solution (C = 37.5 mM) of thiadiazine 6a, a gradual color change (from yellow to colorless) was observed over 24 h. This was not consistent with the structure of sulfoxide 20, as typically thiadiazine sulfoxides are colored [15,16]. Upon working up the reaction mixture, colorless needles [mp 172–173 °C (from Et2O)] were isolated in a 29% yield. HRMS [m/z 315 (MH+)] revealed the addition of “O2”, suggesting oxidation had occurred, while the compound’s lack of color [λmax(DCM) 295 nm, log ε 3.72] indicated a loss of the thiadiazine chromophore. The IR spectrum revealed two C=O stretching bands at 1772 and 1681 cm−1 and a strong band at 1300 cm−1, suggesting the presence of a sulfone functionality. 1H and 13C NMR spectroscopy (see Supplementary Materials) supported an asymmetric structure and were similar to the spectra of 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1-oxide (7a) [8]. Furthermore, similar to thiadiazolone 7a, the product decomposed on silica.
X-Ray quality single crystals were prepared via the slow evaporation of an ethereal solution (5 mg in 1 mL) at ca. 20 °C, in the dark under air, and the structure was fully elucidated by single-crystal X-ray diffraction studies, revealing it to be the ring contracted sulfone, 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide (19) (Figure 2).
The thiadiazole moiety is nearly planar with the plane defined by C1 N1 S1 N2 C2 with an RMSD of 0.033 Å. This plane is inclined at 15.954(8)° to the C bound Ph. However, the plane of the phenyl substituent of the benzoyl group is substantially out of the thiadiazole plane at 49.74(4)°. The carbonyl (C3 O4 N1 C4) is closer to coplanar with the normal thiadiazole plane to normal plane angle, 16.485(9)°, and twisted with respect to the 4-phenyl substituent at 37.12(3)°. The carbonyl oxygen of the thiadiazole moiety makes an intramolecular CH⋯O hydrogen bond with the phenyl H where C11⋯O3 is 2.943 Å. There are no significant intermolecular contacts.
Interestingly, treating pure sulfoxide 7a with m-CPBA in DCM under similar reaction conditions led to no reaction and quantitative recovery of the starting material (Scheme 3). Tentatively, this suggested that the reaction mechanism for the formation of sulfone 19 did not involve the formation of sulfoxide 6a, and that the transformation follows a different pathway. Moreover, treatment of either para-substituted substrates dimethyl 4,4′-(4-oxo-4H-1,2,6-thiadiazine-3,5-diyl)dibenzoate (6b) or 3,5-bis(4-methoxyphenyl)-4H-1,2,6-thiadiazin-4-one (6c) to the same reaction conditions gave complex reaction mixtures (by 1H NMR spectroscopy), and no products could be isolated (Scheme 3). Studies are currently underway to further investigate this ring contraction.

3. Materials and Methods

All chemicals were commercially available except those whose synthesis is herein described. Anhydrous MgSO4 was used for drying organic extracts and all volatiles were removed under reduced pressure. All reaction mixtures and column eluents were monitored by TLC using commercial glass-backed thin layer chromatography (TLC) plates (Merck Kieselgel 60 F254). The plates were observed under UV light at 254 and 365 nm. The technique of flash chromatography was used throughout for all non-TLC scale chromatographic separations using Merck Silica Gel 60 (less than 0.063 mm). Melting points were determined using a Stuart SMP10 digital melting point apparatus. Small-scale (μL) liquid handling measurements were made using variable-volume (1.00–5000.00 μL) single channel Gilson PIPETMAN precision micropipettes (Gilson, Middleton, WI, USA). The solvents used for recrystallisation are indicated after the melting point. IR spectra were recorded on a Thermo Scientific Nicolet iS5 FTIR spectrometer (Thermo Scientific, Waltham, MA, USA) with an iD5 ATR accessory and broad, strong, medium and weak peaks are represented by b, s, m and w, respectively. 1H and 13C NMR spectra were recorded on a Bruker AVANCE III HD machine [at 400 and 100 MHz, respectively (Bruker, Billerica, MA, USA)]. An AVANCE III 300 MHz NMR Spectrometer was also used for reaction monitoring. Chemical shifts (δ) are expressed in ppm. Data are represented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet and/or multiple resonances, br s = broad singlet). Deuterated solvents were used for homonuclear locks and the signals are referenced to the deuterated solvent peaks. For the acquisition of mass spectra, the samples were prepared as detailed below and analyzed by positive ion nanoelectrospray (nES) using a Thermo Scientific™ LTQ Orbitrap XL™ ETD Hybrid Ion Trap-Orbitrap Mass Spectrometer (Thermo Scientific, Waltham, MA, USA). For the X-ray crystallography, each crystal was coated in paraffin oil, mounted on a Molecular Dimensions Litholoop and placed directly into the cold stream of a Bruker D8 Venture diffractometer (Bruker, Billerica, MA, USA). Single-crystal X-ray diffraction data were collected using either a Cu-Kα (λ = 1.5418 Å) IµS 3.0 microfocus source or a Mo sealed tube with Triumph monochromator, using Bruker’s APEX3 program suite [17], with the crystal kept at 100.0 K during data collection. The structures were solved using Olex2 [18], using the SHELXT structure solution program [19], using Intrinsic Phasing, and refined with the SHELXL refinement package using Least Squares minimization [20]. The starting materials 3,5-diphenyl-4H-1,2,6-thiadiazin-4-one 6a, dimethyl 4,4′-(4-oxo-4H-1,2,6-thiadiazine-3,5-diyl)dibenzoate (6b) and 3,5-bis(4-methoxyphenyl)-4H-1,2,6-thiadiazin-4-one (6c) were made according to the literature procedure [21].

2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide (19)

To a stirred solution of 3,5-diphenyl-4H-1,2,6-thiadiazin-4-one (6a) (20.0 mg, 0.075 mmol) in DCM (5 mL) at ca. 20 °C was added one portion of m-CPBA (2 equiv.). After 30 min, the mixture still contained starting material (by 1H NMR); however, the introduction of a further portion of m-CPBA (2 equiv.) led to the complete consumption of the starting material within 30 min. After the reaction was complete, the mixture was transferred to a separation funnel, the organic layer was separated and the aqueous layer was extracted with DCM (3 × 5 mL). The combined organic fractions were washed with brine, dried (MgSO4), filtered and evaporated under reduced pressure. The resulting residue was washed with cold Et2O (3 × 1 mL) and volatiles were removed under reduced pressure to afford the title compound 19 (6.8 mg, 29%) as colorless needles, mp (hot-stage) 172–173 °C (Et2O); λmax(DCM)/nm 295 (log ε 3.72); νmax/cm−1 1772m (C=O), 1681s (C=O), 1597w, 1507w, 1576w, 1560s, 1491w, 1449m, 1416m, 1389s, 1300m, 1258s, 1207s, 1193s, 1177s, 1067m, 1021m, 923m, 898w, 820s, 793m, 785m, 749m, 740w, 715s; δH (400 MHz, Acetone-d6) 8.50–8.45 (2H, m, Ar H), 8.02–7.99 (2H, m, Ar H), 7.87–7.83 (1H, m, Ar H), 7.78–7.74 (1H, m, Ar H), 7.70–7.65 (2H, m, Ar H), 7.62–7.58 (2H, m, Ar H); δC (100 MHz, Acetone-d6) with one C resonance missing, 165.8, 165.1, 155.4, 136.7, 134.9, 132.7, 132.6, 130.1, 129.4, 128.1; m/z (ESI+): 676 ([(M+H+Na)2]+, 9%), 507 (16), 338 (M+H+Na+, 100), 337 (M+Na+, 6, Calculated: 337.0265, found: 337.0244), 321 (M+Na+-O, 12), 306 (M+H+Na+-O2, 5), 282 (M+-O2, 14), 256 (5).

Supplementary Materials

The following information can be downloaded online: molfile, cif file, Figure S1: 1H NMR spectrum of thiadiazole 19 in acetone-d6, Figure S2: 13C NMR spectrum of thiadiazole 19 in acetone-d6, Figure S3: IR spectrum, and Figure S4: Mass spectrum of thiadiazole 19.

Author Contributions

E.B., A.S.K. and P.A.K. conceived the experiments; E.B. conducted the experiments; E.B. isolated and characterized compound 19; S.B.H.P. conducted experiments with additional substrates 6b and 6c; A.S.K. synthesized starting materials 6ac; G.M.R. acquired and analyzed the SC-XRD data for compound 19; E.B. wrote the paper; E.B., A.S.K. and P.A.K. edited the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

E.B. is grateful to the EPSRC CRITICAT Centre for Doctoral Training (E.B. Ph.D. Studentship: EP/L016419/1) for funding and training. S.B.H.P. acknowledges EaSI-CAT for funding. P.A.K. and A.S.K. thank the University of Cyprus for the Internal Grant “Thiadiazine-Based Organic Photovoltaics” and the Cyprus Research Promotion Foundation (Grant Nos. ΣΤΡAΤHΙΙ/0308/06, NEKYP/0308/02, ΥΓΕΙA/0506/19 and ΕΝΙΣΧ/0308/83).

Data Availability Statement

The cif file for compound 19 is deposited with the Cambridge crystallographic data center [CCDC: 2168265].

Acknowledgments

The authors would like to thank Christopher G. Thomson for useful scientific discussions.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Rakitin, O.A. 1,2,5-Thiadiazoles. In Comprehensive Heterocyclic Chemistry IV; Koutentis, P.A., Black, D., Cossy, J., Stevens, C.V., Eds.; Elsevier: Oxford, UK, 2022; Volume 5, Chapter 5.09; pp. 371–406. [Google Scholar] [CrossRef]
  2. Koutentis, P.A. 1,2,5-Thiadiazoles. In Comprehensive Heterocyclic Chemistry III; Zhdankin, V.V., Katritzky, A.R., Ramsden, C.A., Scriven, E.F.V., Taylor, R.J.K., Eds.; Elsevier: Oxford, UK, 2008; Volume 5, Chapter 5.09; pp. 515–565. [Google Scholar] [CrossRef]
  3. Wang, X.; Lawson, J.D.; Marx, M.A.; Smith, C.R.; Kuluk, S. Azaquinazoline Pan-Kras Inhibitors. WO 2022/132200, 23 June 2022. [Google Scholar]
  4. Han, Y.; Achab, A.; Biju, P.; Deng, Y.; Fradera, X.; Guo, L.; He, S.; Kozlowski, J.; Kurulasuriya, R.; Liu, K.; et al. Compounds as Indoleamine 2,3-Dioxygenase Inhibitors. US 10538497, 21 January 2020. [Google Scholar]
  5. Algieri, A.A.; Luke, G.M.; Standridge, R.T.; Brown, M.; Partyka, R.A.; Crenshaw, R.R. 1,2,5-Thiadizole 1-oxide and 1,1-dioxide derivatives. A new class of potent histamine H2-receptor antagonists. J. Med. Chem. 1982, 25, 210–212. [Google Scholar] [CrossRef] [PubMed]
  6. Kalogirou, A.S.; Koutentis, P.A. The Chemistry of Non-S-oxidised 4H-1,2,6-Thiadiazines. Targets Heterocycl. Syst. 2018, 22, 82–118. [Google Scholar] [CrossRef]
  7. Kalogirou, A.S.; Kourtellaris, A.; Koutentis, P.A. The Acid and/or Thermal Mediated Ring Contraction of 4H-1,2,6-Thiadiazines to Afford 1,2,5-Thiadiazoles. Org. Lett. 2016, 18, 4056–4059. [Google Scholar] [CrossRef] [PubMed]
  8. Kalogirou, A.S.; Kourtellaris, A.; Koutentis, P.A. Synthesis and Chemistry of Benzo[e][1,2,6]thiadiazino[3,4-b][1,4]diazepin-10(11H)-ones and Related Ring Transformations. J. Org. Chem. 2021, 86, 5702–5713. [Google Scholar] [CrossRef] [PubMed]
  9. Broumidis, E.; Thomson, C.G.; Gallagher, B.; Sotorríos, L.; McKendrick, K.G.; Macgregor, S.A.; Paterson, M.J.; Lovett, J.E.; Lloyd, G.O.; Rosair, G.M.; et al. The Photochemical Mediated Ring Contraction of 4H-1,2,6-Thiadiazines to Afford 1,2,5-Thiadiazol-3(2H)-one 1-Oxides. Org. Lett. 2023, 25, 6907–6912. [Google Scholar] [CrossRef] [PubMed]
  10. Alkorta, I.; Garcıa-Gomez, C.; de Paz, J.L.G.; Jimeno, M.L.; Aran, V.J. Synthesis, hydrolysis reactions and conformational study of 2-substituted 3,5-diamino-4-nitroso-2H-1,2,6-thiadiazine 1,1-dioxides. J. Chem. Soc. Perkin Trans. 2 1996, 293–297. [Google Scholar] [CrossRef]
  11. Duan, X.-G.; Rees, C.W. Conversion of pyrroles into bi-1,2,5-thiadiazoles: A new route to biheterocycles. J. Chem. Soc. Perkin Trans. 1 1997, 3189–3196. [Google Scholar] [CrossRef]
  12. Kim, K.-J.; Kim, K. Reactions of 5-substituted 3-alkyl- and 3-aryl-isoxazoles with tetrasulfur tetranitride antimony pentachloride complex (S4N4·SbCl5): Complete regioselective formation of 4-substituted 3-acyl- and 3-aroyl-1,2,5-thiadiazoles and their mechanism of formation. J. Chem. Soc. Perkin Trans. 1 1998, 2175–2180. [Google Scholar] [CrossRef]
  13. Rokach, J.; Hamel, P.; Girard, Y.; Reader, G. General method for the preparation of N-monosubstituted 3-isothiazole and 3-(1,2,5-thiadiazole)amines. Preparation of a new class of 2-substituted 1,2,5-thiadiazol-3(2H)-ones. J. Org. Chem. 1979, 44, 1118–1124. [Google Scholar] [CrossRef]
  14. Rees, C.W.; Yue, T.-Y. Conversion of enamines, enamides and triazoles by trithiazyl trichloride into 1,2,5-thiadiazoles. J. Chem. Soc. Perkin Trans. 1 2001, 662–667. [Google Scholar] [CrossRef]
  15. Koutentis, P.A.; Rees, C.W. Chemistry of 4-Dicyanomethylene-1,2,6-thiadiazines. J. Chem. Soc. Perkin Trans. 1 2000, 1081–1088. [Google Scholar] [CrossRef]
  16. Kalogirou, A.S.; Kourtellaris, A.; Koutentis, P.A. Oxidations of 4H-1,2,6-Thiadiazines. ChemistrySelect 2022, 7, e202204204. [Google Scholar] [CrossRef]
  17. Bruker. Apex3, Saint; Bruker AXS Inc.: Madison, WI, USA, 2018. [Google Scholar]
  18. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Cryst. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  19. Sheldrick, G.M. A Short History of SHELX. Acta Cryst. 2008, A64, 112–122. [Google Scholar] [CrossRef] [PubMed]
  20. Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Cryst. 2015, C71, 3–8. [Google Scholar] [CrossRef]
  21. Ioannidou, H.A.; Kizas, C.; Koutentis, P.A. Palladium Catalyzed C–C Coupling Reactions of 3,5-Dichloro-4H-1,2,6-thiadiazin-4-one. Org. Lett. 2011, 13, 3466–3469. [Google Scholar] [CrossRef] [PubMed]
Figure 1. 1,2,5-Thiadiazole-containing drugs and an example of a 1,2,5-thiadiazole 1,1-dioxide with biological activity.
Figure 1. 1,2,5-Thiadiazole-containing drugs and an example of a 1,2,5-thiadiazole 1,1-dioxide with biological activity.
Molbank 2024 m1774 g001
Scheme 1. Ring contractions of 4H-1,2,6-thiadiazines to various 1,2,5-thiadiazole scaffolds [7,8,9].
Scheme 1. Ring contractions of 4H-1,2,6-thiadiazines to various 1,2,5-thiadiazole scaffolds [7,8,9].
Molbank 2024 m1774 sch001
Scheme 2. Syntheses of 1,2,5-thiadiazoles by ring transformations.
Scheme 2. Syntheses of 1,2,5-thiadiazoles by ring transformations.
Molbank 2024 m1774 sch002
Scheme 3. Reactions of thiadiazines 6ac and thiadiazole 1-oxide 7a with m-CPBA.
Scheme 3. Reactions of thiadiazines 6ac and thiadiazole 1-oxide 7a with m-CPBA.
Molbank 2024 m1774 sch003
Figure 2. Single-crystal structure of 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide (19) [CCDC: 2168265].
Figure 2. Single-crystal structure of 2-benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-dioxide (19) [CCDC: 2168265].
Molbank 2024 m1774 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Broumidis, E.; Patterson, S.B.H.; Rosair, G.M.; Koutentis, P.A.; Kalogirou, A.S. 2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-Dioxide. Molbank 2024, 2024, M1774. https://doi.org/10.3390/M1774

AMA Style

Broumidis E, Patterson SBH, Rosair GM, Koutentis PA, Kalogirou AS. 2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-Dioxide. Molbank. 2024; 2024(1):M1774. https://doi.org/10.3390/M1774

Chicago/Turabian Style

Broumidis, Emmanouil, Samuel B. H. Patterson, Georgina M. Rosair, Panayiotis A. Koutentis, and Andreas S. Kalogirou. 2024. "2-Benzoyl-4-phenyl-1,2,5-thiadiazol-3(2H)-one 1,1-Dioxide" Molbank 2024, no. 1: M1774. https://doi.org/10.3390/M1774

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop